By Najat Kantouar
Deltex Medical said it would propose delisting from London's Alternative Investment Market at its next general meeting.
The medical technology group said Tuesday that it would seek approval for the delisting at its general shareholder meeting on Feb. 12.
The group has so far received letters of intent and irrevocable undertakings in favor of the proposal representing around 53.8% of the company's share capital, it said.
The cancellation is conditional upon the approval of at least 75% of the votes. If the proposal is passed at the general meeting, it will become effective on Feb. 21, Deltex said.
Write to Najat Kantouar at najat.kantouar@wsj.com
(END) Dow Jones Newswires
January 21, 2025 03:22 ET (08:22 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。